DoW Kidney Cancer, Academy of Kidney Cancer Investigators – Early-Career Scholar Award
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Kidney Cancer Research Program’s Academy of Kidney Cancer Investigators Early-Career Scholar Award is a competitive research funding opportunity aimed at fostering the next generation of independent kidney cancer investigators. Administered by the Department of Defense through the Defense Health Agency Contracting Activity, this grant supports junior faculty members by pairing them with established mentors who have demonstrated success in both kidney cancer research and mentorship. The program emphasizes not only the scientific merit of proposed research but also the candidate’s potential for long-term career development in the field. Applications must include a detailed project narrative, career development plan, impact statement, and a statement of work with a statistical plan and clearly defined milestones. Preliminary data is required but need not originate from kidney cancer research, allowing for innovative cross-disciplinary approaches. The award provides up to $1.2 million in total costs over a maximum four-year period, with allowable indirect costs based on the institution’s negotiated rate, and all subaward expenses must be included within the primary award’s direct costs. Applicants must be registered in SAM.gov, eBRAP.org, and Grants.gov and must submit a pre-application via eBRAP followed by a full application through either eBRAP (for intramural entities) or Grants.gov (for extramural organizations), with all required attachments in specified formats and filenames. A two-tier review process evaluates technical merit through peer review and programmatic relevance, including alignment with FY26 KCRP focus areas such as basic biology, detection, rare kidney cancers, and novel therapies. Key evaluation priorities include the scholar’s trajectory toward independence and the potential impact of the research on eliminating kidney cancer, particularly in addressing health disparities. Mandatory participation in biennial and annual KCRP-sponsored workshops is required, and recipients must comply with DoDGARs, data management requirements under DoD Instruction 3200.12, and disclose all foreign affiliations of key personnel. Organizations with federal awards exceeding $10 million must report civil, criminal, or administrative proceedings semiannually. Failure to meet deadlines, submit complete documentation, or comply with integrity and registration requirements will result in rejection without exception.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
Summary: Initially created in fiscal year 2019 (FY19), the Kidney Cancer Research Program (KCRP) Academy of Kidney Cancer Investigators (AKCI) is a unique interactive virtual academy providing intensive mentoring, national networking, collaborations, and a peer group for junior faculty. The Academy pairs Early Career Scholars (ECS) with established investigators (Designated Mentors) under the oversight of the AKCI Leadership Team, a Designated Mentor Panel, and the Kidney Cancer Patient Advocates Panel. The AKCI’s overarching goal is to conduct innovative and impactful kidney cancer research while also developing a vital resource, a network of highly productive kidney cancer researchers conducting cutting edge research that advances the state of the field in kidney cancer and leads to new treatments for individuals living with kidney cancer.
Distinctive Features:
· Early-Career Scholar: The FY26 KCRP AKCI-ECSA focuses on both the Scholar’s
research and their career potential in the kidney cancer field.
· Designated Mentor: The Designated Mentor must have a strong record of successful mentorship coupled with a strong record of funding (past and present) and publications in kidney cancer research.
· Preliminary Data: Preliminary data to support the feasibility of the research and approaches are required; however, these data do not need to be derived from the kidney cancer research field.
